10 Best Penny Stocks That Could Triple Your Money

8. Lineage Cell Therapeutics Inc. (NYSE:LCTX)

Lineage Cell Therapeutics Inc. (NYSE:LCTX) is one of the 10 best penny stocks that could triple your money.

On March 24, Lineage Cell Therapeutics Inc. (NYSE:LCTX) announced the launch of COR1, a new preclinical cell therapy program targeting corneal endothelial disease. The company is leveraging its proprietary AlloSCOPE platform to develop scalable off-the-shelf cell therapies aimed at addressing the global shortage of donor corneal cells. Management highlighted the program as a natural extension of its platform and a step toward expanding its presence in ophthalmology while supporting long-term growth. Commenting on the update, CEO Brian Culley stated:

“We have elected to advance the COR1 program into preclinical testing and we also believe the recent accomplishments reported with our AlloSCOPE “5D” manufacturing process could be applied to this program to further reduce production costs through large-scale production.”

Earlier on March 6, Lineage Cell Therapeutics Inc. (NYSE:LCTX) reported fourth quarter revenue of $6.6 million compared to $2.9 million last year. Chief Executive Officer Brian M. Culley stated that 2025 was a very productive year for the Lineage team. Culley emphasized that the company’s mission is to pioneer the emerging field of allogeneic cell therapy outside oncology by applying its proprietary cell manufacturing technology platform, AlloSCOPE, to the production and transplantation of differentiated cell types intended to replace cells a patient has lost or lost function of due to various conditions.

Lineage Cell Therapeutics Inc. (NYSE:LCTX) is working in the US and internationally on developing cell replacement therapies for critical illnesses. Its portfolio includes OpRegen in Phase 2a of clinical trial, OPC1 in Phase 1/2a multicenter clinical trial, ReSonance (ANP1) and PNC1, both in preclinical development stage, and is also developing RND1.